Navigation Links
Transave Completes Successful Phase II Clinical Program for ARIKACE in the Treatment of Pseudomonas Lung Infections
Date:10/19/2009

MONMOUTH JUNCTION, N.J., Oct. 19 /PRNewswire/ -- Transave Inc., today reported additional positive clinical trial results on its lead investigational drug, ARIKACE(TM) (liposomal amikacin for inhalation), an antibiotic that aims to treat chronic lung infections. The latest results along with previously reported data demonstrate significant clinical benefits and complete the company's Phase II program in two indications - for the treatment of lung infections due to the bacterium, Pseudomonas aeruginosa in cystic fibrosis (CF) patients and non-CF bronchiectasis patients.

The new data from the Phase II clinical trial program in CF patients with Pseudomonas lung infections indicate that ARIKACE, delivered at a dose of 560 mg once daily for 28 consecutive days, demonstrated superior clinical benefit compared to placebo as measured by a significant and sustained improvement in lung function, improvement in patient reported outcomes and reduction in Pseudomonas density. In addition, ARIKACE was well-tolerated with overall adverse events comparable to placebo. The Phase II program results were presented Oct. 17 at the 23rd annual North American Cystic Fibrosis Conference in Minneapolis, Minn., by JP Clancy, M.D., of the Children's Hospital of Alabama and the University of Alabama at Birmingham. The Phase II results were from a prospectively designed pooled analysis of two randomized, double-blind and placebo-controlled studies of 105 patients at 33 European and U.S. sites. Preliminary data from a third CF trial which is an on-going open label study where ARIKACE is being dosed in multiple cycles were also presented, showing continued improvement in lung function over repeat cycles.

"We now have consistent positive results from three placebo controlled and three open label studies of ARIKACE in CF and non-CF bronchiectasis patients," said Tim Whitten, Transave's President and Chief Executive Officer. "To date, stu
'/>"/>

SOURCE Transave, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Transave Announces Positive Phase II Results For Once-Daily ARIKACE(TM) in the Treatment of Non-CF Bronchiectasis Patients Who Have Pseudomonas Lung Infections
2. Transave Receives $2.2 Million Cystic Fibrosis Foundation Award for Development of ARIKACE(TM)
3. Transave Announces Positive Phase II Results for Once-Daily Arikace(TM) in the Treatment of Cystic Fibrosis Patients Who Have Pseudomonas Lung Infections
4. ProUroCare Medical Completes Multiple Site Clinical Study for Imaging Prostate Abnormalities
5. BMEYE B.V. Completes EUR 6 Million Series B Financing Round
6. Subsidiary of Nova Biomedical Completes Acquisition of Assets of CCS Medicals Subsidiary, Sanvita, Inc.
7. DBMS Consulting Successfully Completes Roll out of Oracle Health Sciences Applications (OHSA) Suite for SIRO Clinpharm
8. Tetraphase Pharmaceuticals Completes Series B Financing to Support the Advancement of Novel Antibiotic Drug Candidates
9. PDL BioPharma Completes October 1 Special Dividend Payment
10. SyntheMed Completes $1.0 Million Equity Placement
11. ThermalTherapeutic Systems Completes $2.75 Million Series A Financing With Originate Ventures
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... , March 27, 2015  Johnson & Johnson (NYSE: ... 10 a.m. (Eastern Time) on Thursday, April 23, 2015, from ... Investors and other interested parties may access ... Company,s website at www.jnj.com and clicking on the ... meeting will be made available a few hours after the ...
(Date:3/27/2015)... , March 27, 2015 Concord ... "Company") (NYSE: CCM ), a leading specialty ... largest network of radiotherapy and diagnostic imaging centers ... the signing of a purchase agreement under which ... owned subsidiary of the Company, agreed to acquire ...
(Date:3/26/2015)... , March 26, 2015 /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX:PVTTF; ... with a focus on Omega-3 therapies for cardiovascular disease ... it issued 763,752 common shares of the Corporation (the ... for the period of December 5 th , 2014 ... Convertible Notes that is due on or before April ...
Breaking Medicine Technology:Concord Medical Announces Acquisition of Fortis Surgical Hospital in Singapore 2Concord Medical Announces Acquisition of Fortis Surgical Hospital in Singapore 3Pivotal Therapeutics announces payment of interest on outstanding convertible notes 2
(Date:3/27/2015)... March 27, 2015 Since September 2014, the ... his comeback tour after having been in retirement for a ... for the performer to return to touring, and concert events ... for Omaha will likely sell out for the two shows ... BuyCheapTicketsToEvents.com to view the inventory of discounted Garth Brooks ...
(Date:3/27/2015)... Irvine, CA (PRWEB) March 27, 2015 ... nation’s leading providers of business support services to dental ... opening of an affiliated Castle Dental office ... Lake Blvd. Hendersonville, TN 37075, this new Castle Dental ... they can receive the latest in comprehensive, quality dental ...
(Date:3/27/2015)... Pastor and Overseer at The House of Yahweh in Abilene, ... through the Laws of Peace written in the Holy Scriptures ... titled, “Yahweh’s Way-The Great Difference” focuses on the past and ... original biblical instructions has caused mass chaos worldwide. ... the world is based on man-made laws that will never ...
(Date:3/27/2015)... The Thomas Scattergood Behavioral Health ... committed to raising its voice to improve the ... The Scattergood Foundation and The Kennedy Forum are ... Practice through the Annual Scattergood Foundation Innovation Award. ... designed to guide the IBS sufferer through 5 ...
(Date:3/26/2015)... Calif. (PRWEB) March 26, 2015 Let’s ... grocery store. Fresh produce are today’s traffic magnets. Three ... particular supermarket because of their produce department, according to ... than ever as people are looking to add more ... Love Your Produce Manager® Day is April 2. As ...
Breaking Medicine News(10 mins):Health News:Garth Brooks Tickets for Omaha: BuyCheapTicketsToEvents.com Draws Customers by Discounting Prices on 2015 Tickets for Garth Brooks’ Tour Stops at CenturyLink Center 2Health News:Castle Dental® Opens Its First Dental Office in Hendersonville, TN 2Health News:Castle Dental® Opens Its First Dental Office in Hendersonville, TN 3Health News:The World Does Not Have to Continue in Misery, Says Yisrayl Hawkins in New Article 2Health News:SoundsLikeIBS Nominated For 3rd Annual Scattergood Innovation Award 2
... June 29 AutismLink, the largest,autism advocacy organization ... Edward G. Rendell and Speaker of the House ... Autism Bill. The Bill, HB1150, is,scheduled for vote ... up,to $36,000 of autism-related treatment for individuals less ...
... Forest University Baptist Medical Center are about to embark ... cancer treatment will be as effective at eradicating cancer ... mice. , The treatment will involve transfusing specific ... patients with advanced forms of cancer. A similar treatment ...
... provide our veterans with the services they need ... dutifully served us., JAMAICA, N.Y., June 28 ... of the Sixth Congressional,District, announced that he will ask ... Capital Asset Realignment for Enhanced Services,(CARES) and its Enhanced ...
... in non-serious side effects , , FRIDAY June 27 (HealthDay ... the marijuana plant don,t increase the risk of serious ... some non-serious side effects, Canadian scientists report. , The ... of British Columbia (UBC) examined adverse events reported in ...
... the leading national program that has certified ... congratulates the Florida House of Representatives and ... new standards for pharmacy technicians. The new ... increasing patient safety for consumers. The legislation ...
... and WHITEHOUSE STATION, N.J., June 27 /PRNewswire-FirstCall/,-- Schering-Plough ... Co., Inc. (NYSE: MRK ),announce the withdrawal ... combination tablet., The companies also terminated the ... May 2000 to develop and,market a fixed-combination product ...
Cached Medicine News:Health News:AutismLink, Autism Center of Pittsburgh Denounce Senate Autism Bill 2Health News:Cancer 'cure' in mice to be tested in humans 2Health News:Cancer 'cure' in mice to be tested in humans 3Health News:Congressman Gregory W. Meeks to Ask for Suspension of CARES Process at the St. Albans Veteran Campus 2Health News:Drugs With Marijuana Compounds Don't Boost Adverse Events 2Health News:Pharmacy Technician Certification Board (PTCB) Supports Florida's New Patient Safety Solution 2Health News:Pharmacy Technician Certification Board (PTCB) Supports Florida's New Patient Safety Solution 3
Adhesive discs sold on rolls of 100, 250, or 1000 each. Manufactured from non-latex medical grade adhesives & material. One size fits all chest pieces....
For accurately monitoring core temperature and heart and breath sounds....
... enables hospitals to standardize ... to a single temperature ... monitoring disposale probes and ... in their manufacture and ...
... Level 1 enables ... multiparameter patient monitors to ... series. Our temperature monitoring ... cables are superior in ...
Medicine Products: